The Real Fountain of Youth: How Old Drugs Get Covered By New Patents

DSpace/Manakin Repository

The Real Fountain of Youth: How Old Drugs Get Covered By New Patents

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Rosen, Valarie B. en_US
dc.date.accessioned 2012-06-07T20:39:04Z
dc.date.issued 2003 en_US
dc.identifier.citation The Real Fountain of Youth: How Old Drugs Get Covered By New Patents (2003 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852182
dc.description.abstract Until 1995, the term of a patent was 17 years from issue, with a possible extension of five years for delays in market entry related to the Food and Drug Administration drug approval process. Still, many pharmaceutical companies have obtained new patents towards the end of the original patent term for a particular drug. This paper looks at the types of patents that are used to prolong the period of exclusivity for a drug and how they effect entry of generic manufacturers into the market. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject patents, en
dc.subject pharmaceuticals, en
dc.subject generic drugs, en
dc.subject Hatch-Waxman Act en
dc.title The Real Fountain of Youth: How Old Drugs Get Covered By New Patents en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-07T20:39:04Z

Files in this item

Files Size Format View
rosen.pdf 58.89Kb PDF View/Open
rosen.rtf 288.4Kb RTF file View/Open
rosen.html 211.2Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters